Trial · NCT02449044
Adverse events205
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 205
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Upper respiratory tract infection | Infections and infestations | Tolvaptan | 6 | 111 | |
| other | Urinary tract infection | Infections and infestations | Tolvaptan | 18 | 111 | |
| other | Contusion | Injury, poisoning and procedural complications | Tolvaptan | 8 | 111 | |
| other | Fall | Injury, poisoning and procedural complications | Tolvaptan | 6 | 111 | |
| other | Skin laceration | Injury, poisoning and procedural complications | Tolvaptan | 6 | 111 | |
| other | Hypokalaemia | Metabolism and nutrition disorders | Tolvaptan | 13 | 111 | |
| other | Hyponatraemia | Metabolism and nutrition disorders | Tolvaptan | 17 | 111 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Tolvaptan | 8 | 111 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Tolvaptan | 12 | 111 | |
| other | Muscle spasms | Musculoskeletal and connective tissue disorders | Tolvaptan | 6 | 111 | |
| other | Musculoskeletal pain | Musculoskeletal and connective tissue disorders | Tolvaptan | 10 | 111 | |
| other | Dizziness | Nervous system disorders | Tolvaptan | 12 | 111 | |
| other | Headache | Nervous system disorders | Tolvaptan | 15 | 111 | |
| other | Lethargy | Nervous system disorders | Tolvaptan | 6 | 111 | |
| other | Insomnia | Psychiatric disorders | Tolvaptan | 9 | 111 | |
| other | Pollakiuria | Renal and urinary disorders | Tolvaptan | 12 | 111 | |
| other | Renal failure | Renal and urinary disorders | Tolvaptan | 7 | 111 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Tolvaptan | 9 | 111 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Tolvaptan | 11 | 111 | |
| other | Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | Tolvaptan | 7 | 111 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02449044/events?page=2